Tech Company Financing Transactions
Ribometrix Funding Round
Ribometrix closed a $7.8 million funding round on 9/30/2019. Backers included Dementia Discovery Fund and Illumina Ventures.
Transaction Overview
Company Name
Announced On
9/30/2019
Transaction Type
Venture Equity
Amount
$7,800,000
Round
Undisclosed
Proceeds Purpose
The new funding will support the continued development of the Ribometrix discovery platform, which uses sophisticated structural analysis and proprietary assays to identify ligands that bind to highly structured pockets in therapeutically compelling RNAs to modulate protein expression.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6 Davis Dr.
Durham, NC 27709
USA
Durham, NC 27709
USA
Phone
Undisclosed
Website
Email Address
Overview
A platform therapeutics company discovering small molecule drugs that target functional RNA structures to create new avenues to treat human disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Solomon
Chief Scientific Officer
John Reardon
Founder
Kevin Weeks
Vice President
Donald Hertzog
VP - Bus. Development
Martin Williams
VP - Finance
Jonathan Kearns
VP - Human Resources
Denise Kilpatrick
VP - R & D
Katherine Warner
Browse more venture capital transactions:
Prev: 9/30/2019: Evernym venture capital transaction
Next: 9/30/2019: Maka Autonomous Robots venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs